Table 2:

Model-specific and overall vaccine coverage of tetanus–diphtheria–acellular pertussis vaccine

Vaccine delivery modelNo. of vaccinated participantsNo. (%) of vaccinated participants who were vaccinated within the modelModel-specific VCOverall VC
No. (%) of participants vaccinated within the model (95% CI)OR* (95% CI)Adjusted OR (95% CI)Overall no. (%) of participants vaccinated (95% CI)Absolute VC difference, %OR* (95% CI)Adjusted OR (95% CI)
CLSC, n = 246163157 (96.3)157 (63.8) (57.6–69.6)1 (Ref.)1 (Ref.)163 (66.3) (60.1–71.9)Ref.1 (Ref.)1 (Ref.)
FMG, n = 171148116 (78.4)116 (67.8) (60.5–74.4)1.20 (0.79–1.81)1.26 (0.82–1.94)148 (86.5) (80.6–90.9)20.23.28 (1.99–5.57)4.05 (2.36–7.22)
Obstetrics, n = 24120785 (41.1)85 (35.3) (29.5–41.5)0.31 (0.21–0.45)0.30 (0.20–0.44)207 (85.9) (80.9–89.7)19.63.10 (1.99–4.91)3.37 (2.11–5.49)
OGCT, n = 288178127 (71.3)127 (44.1) (38.5–49.9)0.45 (0.31–0.63)0.47 (0.32–0.68)178 (61.8) (56.1–67.2)4.50.82 (0.58–1.17)0.92 (0.62–1.37)
  • Note: CI = confidence interval, CLSC = local community service centre, FMG = family medicine group, OGCT = oral glucose challenge test, OR = odds ratio, Ref. = reference, VC = vaccine coverage.

  • * Odds ratios calculated from univariate logistic regression.

  • Adjusted ORs calculated from multivariable logistic regression, adjusting for maternal age, country of birth (Canada v. other), education, language and the number of previous children.